Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) will hold a board meeting on Thursday, 20 October, to review the financial statements for the third quarter of 2016.
During the second quarter this year, Julphar achieved a growth of 0.94% in profits to AED 54.81 million as compared to AED 54.3 million in the same quarter of the previous year.
On the stock level, Julphar ended Sunday’s session down 0.46% to AED 2.18 after nearly 772,780 shares were exchanged at a value of AED 1.69 million.
